Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04248205 · ClinicalTrials.gov registry record · Phase 4
Ketamine for Post-operative Analgesia in Hemorrhoidectomy
A Phase 4 study of Hemorrhoids, sponsored by University of Oklahoma.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT04248205: Recruiting Phase 4 study of Hemorrhoids, sponsored by University of Oklahoma.
NCT04248205 is a Phase 4 study of Hemorrhoids that is actively recruiting participants, run by University of Oklahoma. The registered enrollment target is 100 participants, above the 58-participant average among 3 other Hemorrhoids trials with a reported enrollment target (72% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04248205, a Phase 4 study of Hemorrhoids, is actively recruiting participants, sponsored by University of Oklahoma.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a prospective, randomized study of ketamine versus no ketamine in approximately 100 patients undergoing hemorrhoidectomy for Grade III or IV hemorrhoids. The participants will be blinded to which treatment arm they are assigned, because participants will be under anesthesia when the ketamine is administered. The investigators will know whether the participant receives ketamine or not.
Primary Outcome
Standardized pain control regimen with ketamine; at two week surgical follow-up visit patient will bring their oxycodone prescription and we will count the number of pills that were taken.
Conditions Studied
Interventions
- DRUG Ketamine
Study Locations (1)
Oklahoma
- University of Oklahoma Health Sciences Center - Oklahoma City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2020-06-15 |
| Est. Completion | 2025-07 |
| Phase | Phase 4 |
What NCT04248205 shows while recruiting
NCT04248205 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, above the 58-participant average among 3 other Hemorrhoids trials with a reported enrollment target (72% higher).
The record links to 1 condition, with Hemorrhoids appearing as the primary indexed condition, and to 1 intervention - of which Ketamine is the first listed.
NCT04248205 reports a single indexed study location in Oklahoma.
Frequently Asked Questions
What is clinical trial NCT04248205 about?
NCT04248205 is a clinical study titled "Ketamine for Post-operative Analgesia in Hemorrhoidectomy". This is a prospective, randomized study of ketamine versus no ketamine in approximately 100 patients undergoing hemorrhoidectomy for Grade III or IV hemorrhoids. The participants will be blinded to which treatment arm they are assigned, because participants will be under anesthesia when the ketamine...
What is the current status of trial NCT04248205?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 100 participants. The study started on 2020-06-15. Estimated completion is 2025-07.
What conditions does trial NCT04248205 study?
This clinical trial studies the following conditions: Hemorrhoids.
What interventions are being tested in trial NCT04248205?
The interventions under investigation include: Ketamine (DRUG).
Who is sponsoring clinical trial NCT04248205?
This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04248205 being conducted?
This trial has 1 study location across Oklahoma. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hemorrhoids
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI